Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1969 1
1971 3
1972 3
1973 3
1974 4
1975 11
1976 24
1977 33
1978 26
1979 42
1980 47
1981 64
1982 41
1983 74
1984 63
1985 60
1986 88
1987 96
1988 118
1989 127
1990 108
1991 149
1992 151
1993 166
1994 123
1995 122
1996 113
1997 119
1998 99
1999 110
2000 117
2001 125
2002 154
2003 133
2004 135
2005 161
2006 186
2007 197
2008 212
2009 216
2010 257
2011 270
2012 289
2013 307
2014 311
2015 339
2016 373
2017 351
2018 428
2019 357
2020 466
2021 507
2022 506
2023 459

Text availability

Article attribute

Article type

Publication date

PubMed for id: 3925

8,303 results

Results by year

Filters applied: . Clear all
Page 1
[Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: experience and recommendations for Mexico. Administración del Patrimonio de la Beneficencia Pública. Asociación de Distrofia Muscular de Occidente].
Vázquez-Cárdenas NA, Ibarra-Hernández F, López-Hernández LB, Escobar-Cedillo RE, Ruano-Calderón LA, Gómez-Díaz B, García-Calderón N, Carriedo-Dávila MF, Rojas-Hurtado LG, Luna-Padrón E, Coral-Vázquez RM; Administración del Patrimonio de la Beneficencia Pública; Asociación de Distrofia Muscular de Occidente. Vázquez-Cárdenas NA, et al. Rev Neurol. 2013 Nov 16;57(10):455-62. Rev Neurol. 2013. PMID: 24203668 Free article. Spanish.
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.
Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives.
Araujo APQC, Carvalho AAS, Cavalcanti EBU, Saute JAM, Carvalho E, França MC Junior, Martinez ARM, Navarro MMM, Nucci A, Resende MBD, Gonçalves MVM, Gurgel-Giannetti J, Scola RH, Sobreira CFDR, Reed UC, Zanoteli E. Araujo APQC, et al. Arq Neuropsiquiatr. 2017 Aug;75(8):104-113. doi: 10.1590/0004-282x20170112. Arq Neuropsiquiatr. 2017. PMID: 28813090 Free article.
[The technology of treatment of multiple sclerosis with long-term immunomodulating drugs (disease modifying drugs--DMD)--beta-interferons and glatiramer-acetate].
Federal service on surveillance in healthcare and social development (Roszdravnadzor). Federal service on surveillance in healthcare and social development (Roszdravnadzor). Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):86-92. Zh Nevrol Psikhiatr Im S S Korsakova. 2011. PMID: 21916162 Russian.
American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation.
Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA, Finder JD, Iannaccone ST, Jacobson LE, Kohn GL, Motoyama EK, Moxley RT, Schroth MK, Sharma GD, Sussman MD. Birnkrant DJ, et al. Chest. 2007 Dec;132(6):1977-86. doi: 10.1378/chest.07-0458. Chest. 2007. PMID: 18079231
8,303 results